Policlinico Gemelli

Roma 00195

1 studies enrolling now · 10 studies all time

What they study most

Alzheimer Disease, Atrial Fibrillation, Atrial Fibrillation New Onset, COVID-19, Diabetes Mellitus, Type 1, Endometrial Adenocarcinoma, Hemorrhage, Idiopathic Pulmonary Fibrosis, Lung Diseases, Interstitial, Myelodysplastic Syndromes, Non-small Cell Lung Cancer Metastatic, Percutaneous Coronary Intervention

Studies at this site

• A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma — Recruiting now
• Predictive Multimodal Signatures Associated With Response to Treatment and Prognosis of Patients With Stage IV Non-small Cell Lung Cancer — Running, not enrolling
• Natural History of COVID-19-Related Atrial Fibrillation — Status unconfirmed
• Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) — Completed
• A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care — Completed
• Efficacy and Safety of Nintedanib Co-administered With Sildenafil in Idiopathic Pulmonary Fibrosis Patients With Advanced Lung Function Impairment — Completed
• Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo — Completed
• Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3) — Completed
• Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) — Completed
• Reversal of Dabigatran Anticoagulant Effect With Idarucizumab — Completed